Mount Sinai Medical Center (Site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place

New York, New York 10029

0 studies enrolling now · 3 studies all time

What they study most

Covid19

Studies at this site

• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 — Completed
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) — Completed
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) — Completed